About YESINTEK

YESINTEK is a medication that contains the active ingredient USTEKINUMAB, which is used to treat various autoimmune diseases. It is a human monoclonal antibody that targets specific proteins in the body, helping to reduce inflammation and modulate the immune system. YESINTEK is prescribed for patients with conditions such as moderate to severe plaque psoriasis, psoriatic arthritis, and Crohn's disease.

Key Benefits & Uses

Treatment of moderate to severe plaque psoriasis in adults
Treatment of active psoriatic arthritis in adults
Treatment of moderately to severely active Crohn's disease in adults

Active Ingredient & Action

USTEKINUMAB, the active ingredient in YESINTEK, works by binding to specific proteins in the body, including interleukin-12 (IL-12) and interleukin-23 (IL-23). This binding action helps to reduce the production of pro-inflammatory chemicals, which contribute to the development of autoimmune diseases. By reducing inflammation and modulating the immune system, USTEKINUMAB helps to alleviate symptoms and slow disease progression.

Important Notes

Patients taking YESINTEK should be monitored for signs of infection and other potential side effects. It is essential to follow the prescribed dosage and administration instructions carefully. Before starting treatment with YESINTEK, patients should discuss their medical history and any potential allergies with their healthcare provider. Regular follow-up appointments and laboratory tests may be necessary to ensure the safe and effective use of YESINTEK.